Bacterial vaginosis
Conditions
Interventions
Control group:Ornidazole Vaginal Suppository 0.5g, Vaginal medication, qd, 5 days
test group:Ornidazole Vaginal Gel 0.5g, Vaginal medication, q.d, 5 days
Sponsors
West China Second University Hospital, Sichuan University
Eligibility
Sex/Gender
Female
Age
20 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. Patients in accordance with bacterial vaginosis diagnostic standards; 2. Patients have sexual life and not in menses. Age: 20-55; 3. Patients with good follow-up and compliance conditions and should sign the Informed Consent Form; 4. Menstrual laws,away from the next menstrual flow at least 7 days.
Exclusion criteria
Exclusion criteria: 1. The patients have other reproductive tract infections, such as trichomonas vaginitis, vulvovaginal vaginosis; 2. Patients allergy to nitroimidazoles and any other two or more drugs; 3. Pregnant and lactating women; 4. Patients have heart, liver, kidney, hematopoietic and endocrine system diseases; 5. Abnormal laboratory test results show clinical significance: (1) A LT and AST are 3 times more than normal value; (2) WBC<3.6*10^9/L; (3) PLT<70*10^9/L; (4) Abnormality of electrocardiogram has clinical significance; (5) BUN and Cr are greater than normal value; 6. Psychopath and the patients that can not cooperate for other reasons; 7. Patients participated other clinical trials during last 3 months; 8. Patients have used any vaginal local drug during the last one week; 9. Patients with alcohol and drug abuse experience; 10. Patients used system antibiotics at the same time; 11. Any other unsuitable reasons for the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy on bacteria examinations (3-7 days after treatment);Comprehensive efficacy (3-7 days after the treatme); | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical efficacy (28±2 days after the treatment);Efficacy on bacteria examinations (28±2 days after treatment);Comprehensive efficacy (28±2 days after the treatm);Clinical efficacy (3-7 days after the treatment); | — |
Countries
China
Contacts
Public ContactLina Hu, Hongwei Liu
Outcome results
None listed